Business Context and Reporting Period
This Form 8-K Current Report was filed by Autonomix Medical, Inc. (AMIX) on September 14, 2026. The filing reports a corporate governance event: the expansion of the Board of Directors and the appointment of a new independent director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or operational metrics.
Material Changes
- Board Expansion: The Board of Directors increased its size from five to six members.
- New Appointment: Sandra Kalter was appointed as an independent member of the Board, effective immediately on September 14, 2026.
Guidance, Outlook, and Management Commentary
Management Commentary: The Company stated that Ms. Kalter's extensive experience in the medical device industry, particularly her tenure at Medtronic plc and her regulatory expertise, qualifies her to serve as a director. She will participate in the standard compensation program for non-employee directors but has not yet been appointed to any specific Board committees.
Risks and Contingencies: The filing explicitly states there are no arrangements or understandings regarding her selection, no family relationships with other directors or officers, and no material interests in transactions requiring disclosure under Item 404(a) of Regulation S-K.
Key Facts for Investor Verification
- Verify the effective date of Sandra Kalter's appointment (September 14, 2026).
- Confirm the new total size of the Board of Directors (six members).
- Review Ms. Kalter's background, specifically her role as Chief Regulatory Counsel at Medtronic plc (2011–2025) and her recent advisory role with iTolerance.
- Note that no committee assignments have been made to the new director at the time of filing.